The potential use of biomarkers for the diagnosis, prognosis, and management of IgA nephropathy is emerging.1 Learn more as IgANexus faculty Dr Jonathan Barratt and Dr Dana Rizk provide an introduction on the role of biomarkers and an in-depth review of their impact in IgA nephropathy.
References: 1. Selvaskandan H, Shi S, Twaij S, Cheung CK and Barratt J (2020) Monitoring Immune Responses in IgA Nephropathy: Biomarkers to Guide Management. Front. Immunol. 11:572754. https://doi.org/10.3389/fimmu.2020.572754